Feature

Infectious Disease Surveillance and Testing: What Clinical Labs Should Expect During the FIFA World Cup

Large-scale global events can heighten infectious disease risks, making laboratory preparedness critical for surveillance and testing, particularly for measles and other highly transmissible diseases

Written byRodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc
Reviewed byMiriam Bergeret, MSc
| 4 min read
Crowd at a major international event raising public health concerns.
Register for free to listen to this article
Listen with Speechify
0:00
4:00

As the world prepares for the upcoming FIFA World Cup, public health experts and laboratory professionals are increasingly evaluating the infectious disease risks associated with one of the largest mass gathering events on the planet. Millions of international travelers, athletes, media personnel, and spectators will converge across multiple venues and transportation hubs, creating an environment where communicable diseases can spread rapidly across borders. While global sporting events are designed to unite cultures and celebrate international competition, they also create ideal conditions for infectious disease transmission due to crowd density, international mobility, and prolonged close contact among attendees.

Among the growing concerns is measles, a highly contagious viral disease that has resurged globally in recent years despite the availability of safe and effective vaccines. For medical laboratories and public health systems, the World Cup represents a critical opportunity to strengthen surveillance capacity, diagnostic preparedness, and outbreak response strategies before increased international travel accelerates potential transmission events

The intersection of public health preparedness, laboratory medicine, international travel, and global sporting events highlights how essential diagnostic infrastructure has become in protecting global health security. The recent events tied to a hantavirus outbreak linked to a Dutch expedition cruise ship has only heightened international concern regarding infectious disease preparedness.

Why measles deserves serious attention

Public health officials should be highly concerned about measles because of its extraordinary transmissibility and the growing number of measles outbreaks in the US and worldwide. 

Measles remains one of the most contagious infectious diseases known, capable of spreading through airborne transmission and lingering in enclosed spaces for up to two hours after an infected person leaves the area. Measles has a basic reproduction number (R0) between 12 and 18, meaning a single infected person will infect an average of 12 to 18 other people in a completely unvaccinated and susceptible population. A single infected individual can expose large numbers of susceptible people in airports, hotels, public transportation systems, restaurants, and sporting venues before symptoms are even recognized.

The concern surrounding measles is amplified by declining vaccination rates in several countries, vaccine hesitancy fueled by misinformation, and disruptions in routine immunization programs during and after the COVID-19 pandemic

Global health agencies have warned that immunity gaps are widening in certain populations, increasing the likelihood of imported measles cases during periods of intense international travel. Large international gatherings like the World Cup create opportunities for both importation events and secondary transmission chains that can spread far beyond the host country.

Another challenge is that measles infections often begin with nonspecific symptoms such as fever, cough, runny nose, and conjunctivitis before the characteristic rash develops. Early-stage symptoms may resemble influenza, COVID-19, RSV, or other respiratory illnesses, making clinical diagnosis difficult without laboratory confirmation. This increases the importance of rapid diagnostic testing and vigilant public health surveillance during mass gathering events.

Operational challenges for diagnostic laboratories

Even a moderate increase in suspected measles cases could place considerable strain on clinical and public health laboratories. Confirming measles requires specialized laboratory testing, including molecular diagnostics such as reverse transcription polymerase chain reaction (RT-PCR) and serologic testing for measles-specific IgM antibodies. In some situations, viral genotyping may also be necessary to support epidemiologic investigations and identify transmission pathways.

Laboratories may experience increased specimen volumes, higher reporting demands, and pressure to maintain rapid turnaround times during periods of elevated testing activity. Healthcare facilities may also see a surge in “rule-out” testing requests because clinicians must quickly differentiate measles from other viral illnesses with similar presentations. During major international events, even isolated suspected cases can trigger extensive contact tracing and public health investigations.

Operational preparedness therefore becomes critically important. Laboratories should evaluate surge capacity plans, ensure adequate staffing coverage, verify testing supply inventories, and strengthen communication pathways with epidemiologists and infection prevention teams. Biosafety procedures, specimen handling protocols, and reporting workflows should also be reviewed before large-scale international events begin.

In addition, healthcare systems must recognize that laboratories are central to outbreak response efforts. Rapid identification and reporting of suspected cases can significantly reduce transmission risk by supporting timely isolation measures and public health interventions.

Other infectious disease risks associated with the FIFA World Cup

While measles is a major concern, it is not the only infectious disease threat associated with large international sporting events. Public health experts are also monitoring respiratory viruses, such as influenza, meningitis, hantavirus, RSV, and emerging COVID-19 variants, because crowded venues and international travel facilitate rapid respiratory transmission. Seasonal respiratory surges occurring simultaneously with the tournament could further complicate diagnostic workflows and strain healthcare resources.

Gastrointestinal illnesses, including norovirus and foodborne outbreaks, also remain important considerations in high-density hospitality environments. Hotels, restaurants, fan gatherings, and transportation hubs can all contribute to rapid spread if proper infection prevention and food safety measures are not maintained.

Depending on geographic location and climate conditions, vector-borne diseases, such as Ebola, dengue fever, chikungunya, and Marburg, Nipah, and Zika viruses, may also require enhanced surveillance efforts during the tournament period. Increased traveler movement into regions where mosquito-borne illnesses are endemic may elevate exposure risks for international visitors.

Another growing concern involves antimicrobial resistance, or AMR. International travel contributes to the global movement of resistant organisms, making surveillance and infection prevention strategies increasingly important. Clinical laboratories play a key role in identifying resistant pathogens and supporting antimicrobial stewardship and efforts to raise public awareness during periods of elevated travel and healthcare utilization.

Lessons from previous global sporting events

Past Olympic Games, FIFA tournaments, and other international mass gatherings have demonstrated the importance of early preparedness, strong laboratory coordination, and enhanced surveillance systems. One of the most important lessons learned is that infectious disease monitoring must begin long before the opening ceremony. Healthcare systems that establish clear communication pathways, surge testing plans, and real-time reporting capabilities are better positioned to rapidly identify and contain outbreaks.

The COVID-19 pandemic fundamentally changed how the world approaches mass gathering preparedness. Public health officials now recognize the importance of rapid diagnostics, genomic surveillance, syndromic monitoring, and international collaboration in detecting emerging threats. Investments made in laboratory infrastructure during the pandemic may provide valuable support for future surveillance efforts tied to major global events.

Importantly, preparedness efforts should not create unnecessary fear among travelers or the public. Most attendees will not experience infectious disease complications. However, history consistently demonstrates that proactive surveillance and strong laboratory readiness remain essential to minimizing the public health impact of mass gatherings.

On the front lines of global health security

The World Cup represents far more than a sporting event—it is also a global public health challenge that requires coordinated preparedness across laboratories, healthcare systems, and public health agencies. Measles surveillance and diagnostic readiness should remain a priority given the disease’s high transmissibility and ongoing global resurgence. At the same time, laboratories must remain vigilant for other respiratory, gastrointestinal, and travel-associated infectious threats.

Clinical laboratories now serve as frontline components of global health security, providing the rapid diagnostics and surveillance capabilities needed to identify outbreaks before they escalate. As international travel continues to expand, and global mass gatherings increase in scale, proactive planning, strong surveillance systems, and coordinated communication will remain essential for protecting both local communities and international visitors alike.

Add Today's Clinical Lab as a preferred source on Google

Add Today's Clinical Lab as a preferred Google source to see more of our trusted coverage.

About the Author

  • Photo portrait of  RODNEY E. ROHDE, PHD, MS, SM(ASCP)CM, SVCM, MBCM, FACSC
    Rodney E. Rohde, PhD, is University Distinguished Regents’ Professor and chair of the Medical Laboratory Science Program in the College of Health Professions at Texas State University, where he also serves as the associate director of the Translational Health Research Center. He holds certifications as a specialist in virology, specialist in microbiology, and molecular biologist from the American Society for Clinical Pathology. Rohde is considered a subject matter expert in rabies and methicillin-resistant Staphylococcus aureus (MRSA), infection prevention and control, as well as other public health and medical laboratory topics. Rohde has more than 30 years of experience, including a decade with the Texas Department of State Health Services – Zoonosis Control Division and Bureau of Laboratories and the CDC as a visiting scientist from 1992–2002. Find Rohde on LinkedIn, YouTube, and Twitter @RodneyRohde and @TXST_CLS.
    View Full Profile

About the Reviewer

Related Topics

Loading Next Article...
Loading Next Article...